BUPRENORPHINE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Buprenorphine Market, By Brand (Sublocade (buprenorphine extended‐release), Suboxone (buprenorphine and naloxone), Brixadi (buprenorphine extended‐release), Zubsolv (buprenorphine and naloxone), and Others (Belbuca, Butrans and among others)), By Type (Branded and Generics), By Route of Administration (Injectable (Intravenous, Intramuscular, Subcutaneous), Sublingual, Buccal, Transdermal, and Others), By Dosage Form (Injectable Solutions, Patches, Films, Others (Tablets, etc.)), By Indication (Opioid Use Disorder (OUD), Pain Management, Acute Pain, Chronic Pain), By Formulation Type (Single Drug Formulation, Fixed Dose Combination), By Age Group (Adults, Pediatric), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)

Published In: 05 Mar, 2026
Code: CMI4237
Page number: 168
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Buprenorphine is the first medication to treat opioid use disorder that may be prescribed or distributed in doctor's offices, vastly expanding access to care. Buprenorphine should be prescribed as a component of a thorough treatment plan that includes counseling and other services to give patients a whole-person approach, as is the case with all drugs used in therapy. Buprenorphine provides a number of benefits for those with opioid use disorder and for those for whom therapy at an opioid treatment center is uncomfortable or inappropriate.

The following buprenorphine products are approved for the treatment of opioid use disorder by the U.S. FDA:

Generic buprenorphine/naloxone sublingual tablets
Buprenorphine sublingual tablets (Subutex)
Buprenorphine/naloxone sublingual films (Suboxone)
Buprenorphine/naloxone sublingual tablets (Zubsolv)
Buprenorphine/naloxone buccal film (Bunavail)
Buprenorphine implants (Probuphine)
Buprenorphine extended-release injection (Sublocade)

Market Dynamics

Increasing approval of buprenorphine by regulatory authorities for subcutaneous use is expected to increase the global buprenorphine market over the forecast period. For instance, in March, 2018, Indivior PLC, a pharmaceutical company, announced that SUBLOCADE (buprenorphine extended-release) injection, for subcutaneous use (CIII), is available in the U.S. The U.S. Food and Drug Administration (FDA) has granted approval for the use of SUBLOCADE for the treatment of moderate to severe opioid use disorder (OUD) in adult patients who have started therapy with a transmucosal buprenorphine-containing medication and have undergone dose titration for at least seven days. It should only be given by medical professionals, and it should be part of a comprehensive treatment plan that also includes counseling and psychosocial support.

Key features of the study

This report provides in-depth analysis of the global buprenorphine market, and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR%) for the forecast period (2025–2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global buprenorphine market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Mallinckrodt, Noramco, Unichem Laboratories Ltd., Sanofi, Johnson Matthey, Arevipharma Gmbh, Resonance Laboratories Pvt. Ltd., Sun Pharmaceutical Industries Limited, Rusan Pharma Ltd. Micro Orgo Chem, Faran Shimi Pharmaceutical, Indivior PLC, Titan Pharmaceuticals, Inc., Hikma Pharmaceuticals PLC.
Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global buprenorphine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global buprenorphine market

Market Segmentation

Brand Insights (Revenue, USD Mn, 2021 - 2033)
- Sublocade (buprenorphine extended‐release)
- Suboxone (buprenorphine and naloxone)
- Brixadi (buprenorphine extended‐release)
- Zubsolv (buprenorphine and naloxone)
- Others (Belbuca, Butrans and among others)
Type Insights (Revenue, USD Mn, 2021 - 2033)
- Branded
- Generics
Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
- Injectable
  - Intravenous
  - Intramuscular
  - Subcutaneous
- Sublingual
- Buccal
- Transdermal
- Others
Dosage Form Insights (Revenue, USD Mn, 2021 - 2033)
- Injectable Solutions
- Patches
- Films
- Others (Tablets, etc.)
Indication Insights (Revenue, USD Mn, 2021 - 2033)
- Opioid Use Disorder (OUD)
- Pain Management
- Acute Pain
- Chronic Pain
Formulation Type Insights (Revenue, USD Mn, 2021 - 2033)
- Single Drug Formulation
- Fixed Dose Combination
Age Group Insights (Revenue, USD Mn, 2021 - 2033)
- Adults
- Pediatric
Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Mn, 2021 - 2033)
- North America
  - U.S.
  - Canada
- Latin America
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
- Europe
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
- Asia Pacific
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
- Middle East
  - GCC Countries
  - Israel
  - Rest of Middle East
- Africa
  - South Africa
  - North Africa
  - Central Africa
Key Players Insights
- Indivior
- Braeburn
- Camurus
- Collegium Pharmaceutical
- Teva Pharmaceuticals
- Hikma Pharmaceuticals USA
- Alvogen
- Camber Pharmaceuticals
- Apotex
- Dr Reddy’s Laboratories
- Orexo
- Rusan Pharma
- Arevipharma
- Noramco
- Neuraxpharm

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Global Buprenorphine Market, By Brand
  - Global Buprenorphine Market, By Type
  - Global Buprenorphine Market, By Route of Administration
  - Global Buprenorphine Market, By Dosage Form
  - Global Buprenorphine Market, By Indication
  - Global Buprenorphine Market, By Formulation Type
  - Global Buprenorphine Market, By Age Group
  - Global Buprenorphine Market, By Distribution Channel
  - Global Buprenorphine Market, By Region
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER’s Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trends
Global Buprenorphine Market, By Brand, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Sublocade (buprenorphine extended‐release)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Suboxone (buprenorphine and naloxone)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Brixadi (buprenorphine extended‐release)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Zubsolv (buprenorphine and naloxone)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others (Belbuca, Butrans and among Others)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Branded
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Generics
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Route of Administration, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Injectable
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
    - Intravenous
    - Intramuscular
    - Subcutaneous
- Sublingual
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Buccal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Transdermal
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Dosage Form, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Injectable Solutions
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Patches
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Films
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Others (Tablets, etc.)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Indication, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Opioid Use Disorder (OUD)
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pain Management
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Acute Pain
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Chronic Pain
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Formulation Type, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Single Drug Formulation
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Fixed Dose Combination
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Age Group, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Adults
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pediatric
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Distribution Channel, 2021-2033, (USD Mn)
- Introduction
  - Market Share Analysis, 2026 and 2033 (%)
  - Y-o-Y Growth Analysis, 2022 - 2033
  - Segment Trends
- Hospital Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Retail Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Online Pharmacies
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Global Buprenorphine Market, By Region, 2021 - 2033, Value (USD Mn)
- Introduction
  - Market Share (%) Analysis, 2026,2029 & 2033, Value (USD Mn)
  - Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Mn)
  - Regional Trends
- North America
  - Introduction
  - Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - U.S.
    - Canada
- Latin America
  - Introduction
  - Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Europe
  - Introduction
  - Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - Germany
    - U.K.
    - Spain
    - France
    - Italy
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country, 2021 - 2033, Value (USD Mn)
    - China
    - India
    - Japan
    - Australia
    - South Korea
    - ASEAN
    - Rest of Asia Pacific
- Middle East
  - Introduction
  - Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
    - GCC Countries
    - Israel
    - Rest of Middle East
- Africa
  - Introduction
  - Market Size and Forecast, By Brand, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Dosage Form, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Formulation Type, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Mn)
  - Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Mn)
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Indivior
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Braeburn
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Camurus
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Collegium Pharmaceutical
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Teva Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hikma Pharmaceuticals USA
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Alvogen
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Camber Pharmaceuticals
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Apotex
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Dr Reddy’s Laboratories
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Orexo
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Rusan Pharma
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Arevipharma
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Noramco
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Neuraxpharm
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
References and Research Methodology
- References
- Research Methodology
- About us

*Browse 32 market data tables and 28 figures on 'Buprenorphine Market' - Global forecast to 2033

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now